Zydus Lifesciences has received one observation for its manufacturing plant at SEZ II, Ahmedabad from the USFDA. The USFDA conducted cGMP inspection at the said facility from September 21 to 28, 2026 and concluded the inspection with one observation. There were no data integrity related observations.
Zydus Lifesciences is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovating, manufacturing, marketing and selling of finished dosage human formulations, active pharmaceutical ingredients (APIs), animal healthcare products and consumer wellness products.
